NanoView Biosciences
Share
Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from NanoView Biosciences, Biotechnology company, Boston, MA.
NanoView Biosciences is focused on enabling worldwide life science researchers to better understand the biological role of extracellular vesicles, including exosomes and viral vectors, and their potential use as biomarkers for disease.
05/18/2022
If you're at , don't miss our session today where we'll discuss how LentiView provides rapid and actionable data on virus size, empty/full ratio, viral titer and pseudotype characterization without the need for purification!
05/18/2022
Wrapping up a great couple of days at our workshop at the Medical University in Graz!
05/17/2022
We're here and ready for day 2 of ! If you're here, come over and see what's new in viral vector characterization.
05/16/2022
We're here for our first ever ! If you're here, come and see us at booth 529 to learn all there is to know about LentiView and how we use it to characterize without the need for purification.
05/06/2022
If you're at it's your last chance to come and talk to us about purification-free characterization of exosomes and viral vectors with ExoView! Come and find us at booth 412.
04/22/2022
We're very proud to announce that since its launch, more than 150 papers have now been published in high profile journals using our ExoView system! Our congratulations to the authors on their fantastic work. You can find all ExoView publications here: https://bit.ly/38aFbP9
03/10/2022
Chimeric antigen receptor (CAR) T cell therapy is a cellular therapy that redirects a patient's T cells to specifically target and destroy tumor cells. Read our latest blog post to find out more about this powerful technique: https://bit.ly/3hUeKyO
CAR-T Cell Therapy Via Lentiviral Delivery Chimeric antigen receptor (CAR) T cell therapy is a cellular therapy that redirects a patient's T cells to specifically target and destroy tumor cells...
03/01/2022
It's great to be here in Rotterdam this week at Circulating Biomarkers, Exosomes & Liquid Biopsy Europe 2022. There have been some very interesting talks already and we've enjoyed some great conversations about and !
02/25/2022
Thank you so much to everyone who attended our webinar yesterday where we demonstrated our new characterization capability. The recording is still being processed but you can already request it here to be notified as soon as it's ready:
Virus Characterization With ExoView - Webinar Registration In this webinar we will highlight the new virus characterization capabilities of the ExoView platform, including the new LentiView and ViroFlex chips
02/21/2022
Just three days left to register for our upcoming webinar showing our new virus characterization capability! Come and see how we can provide rapid and actionable data on virus size, empty/full ratio, viral titer and pseudotype characterization here: https://bit.ly/350rbWS
02/18/2022
Lentivirus Versus AAV – Which Is Best For Gene Delivery And Editing? Gene therapy is considered the future of resolving human genetic diseases. There are currently multiple ways of editing the genome, such as Zinc fingers nucleases (ZFN), Transcription activator-like nucleases (TALENS) or CRISPR/Cas9...
02/09/2022
If you're still here, it's your last chance to catch us at ! Come and find out how we can help your and characterization on booth 625.
Click here to claim your Sponsored Listing.
Category
Telephone
Address
Boston, MA
02135